By Suzanne Burdick, Ph.D., Children’s Health Defense, Jan. 23, 2024
Suzanne Burdick, Ph.D., is a reporter and researcher for The Defender based in Fairfield, Iowa.
The children were mistakenly administered either Pfizer’s Abrysvo or GSK’s Arexvy respiratory syncytial virus, or RSV, vaccines. Both are approved by the U.S. Food and Drug Administration for adults ages 60 and older — but not for children or babies.
Nearly 130 pregnant women and 25 children under age 2 were given the wrong respiratory syncytial virus (RSV) vaccine, according to the Centers for Disease Control and Prevention (CDC).
The children were mistakenly administered either Pfizer’s Abrysvo or GSK’s (formerly GlaxoSmithKline) Arexvy RSV vaccines. Both are approved by the U.S. Food and Drug Administration (FDA) for adults ages 60 and older — but not for children or babies.